Clinical classification of cancer cachexia: Phenotypic correlates in human skeletal muscle

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Johns, Neil ^a   Hatakeyama, Shinji ^b   Stephens, Nathan A ^a   Degen, Martin ^b   Degen, Simone ^b   Frieauff, Wilfried ^b   Lambert, Christian ^b   Ross, James A ^a   Roubenoff, Ronenn ^c   Glass, David J ^c   Jacobi, Carsten ^b   Fearon, Kenneth C H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 5; BECLIN; C REACTIVE PROTEIN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUSCLE PROTEIN; MYOSIN HEAVY CHAIN; RNA; SMAD3 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTOPHAGY; CACHEXIA; CLINICAL ARTICLE; CLINICAL CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE BIOPSY; MUSCLE CELL; PANCREAS CANCER; PHENOTYPE; RECTUS ABDOMINIS MUSCLE; SIGNAL TRANSDUCTION; UPPER GASTROINTESTINAL CANCER; UPPER GASTROINTESTINAL TRACT; WEIGHT REDUCTION; WESTERN BLOTTING;

AGED; AUTOPHAGY; BIOLOGICAL MARKERS; BODY MASS INDEX; CACHEXIA; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEOPLASMS; PHENOTYPE; SIGNAL TRANSDUCTION; SMAD PROTEINS; WEIGHT LOSS;

EID: 84896771237     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083618     Document Type: Article

References (52)

1. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, et al. (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12: 489-495.
2. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15: 6973-6979.
3. Basu R, Basu A, Nair KS (2002) Muscle changes in aging. J Nutr Health Aging 6: 336-341. (Pubitemid 36118983)
4. Eley HL, Skipworth RJ, Deans DA, Fearon KC, Tisdale MJ (2008) Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2alpha may signal skeletal muscle atrophy in weightlosing cancer patients. Br J Cancer 98: 443-449. (Pubitemid 351161247)
5. Weber MA, Kinscherf R, Krakowski-Roosen H, Aulmann M, Renk H, et al. (2007) Myoglobin plasma level related to muscle mass and fiber composition: a clinical marker of muscle wasting? J Mol Med (Berl) 85: 887-896. (Pubitemid 47077115)
6. Schmitt TL, Martignoni ME, Bachmann J, Fechtner K, Friess H, et al. (2007) Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia. J Mol Med (Berl) 85: 647-654. (Pubitemid 46870894)
7. Weber MA, Krakowski-Roosen H, Schroder L, Kinscherf R, Krix M, et al. (2009) Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol 48: 116-124.
8. Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, et al. (2009) During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185: 1083-1095.
9. Bassett DR Jr, Howley ET (2000) Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc 32: 70-84. (Pubitemid 30056961)
10. Fearon KC, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16: 153-166.
11. Gallagher IJ, Stephens NA, Macdonald AJ, Skipworth RJ, Husi H, et al. (2012) Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies. Clin Cancer Res.
12. Williams JP, Phillips BE, Smith K, Atherton PJ, Rankin D, et al. (2012) Effect of tumor burden and subsequent surgical resection on skeletal muscle mass and protein turnover in colorectal cancer patients. Am J Clin Nutr 96: 1064-1070.
13. Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, et al. (2009) Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 296: C1248-1257.
14. Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF (1995) The validity of self-reports of past body weights by U.S. adults. Epidemiology 6: 61-66.
15. Stunkard AJ, Albaum JM (1981) The accuracy of self-reported weights. Am J Clin Nutr 34: 1593-1599.
16. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, et al. (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 97: 2333-2338. (Pubitemid 39552474)
17. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, et al. (2008) A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33: 997-1006.
18. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, et al. (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9: 629-635.
19. Harrison BC, Allen DL, Leinwand LA (2011) IIb or not IIb? Regulation of myosin heavy chain gene expression in mice and men. Skelet Muscle 1: 5.
20. Aulino P, Berardi E, Cardillo VM, Rizzuto E, Perniconi B, et al. (2010) Molecular, cellular and physiological characterization of the cancer cachexiainducing C26 colon carcinoma in mouse. BMC Cancer 10: 363.
21. Sciote JJ, Rowlerson AM, Hopper C, Hunt NP (1994) Fibre type classification and myosin isoforms in the human masseter muscle. J Neurol Sci 126: 15-24. (Pubitemid 24305254)
22. Smerdu V, Karsch-Mizrachi I, Campione M, Leinwand L, Schiaffino S (1994) Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. Am J Physiol 267: C1723-1728.
23. Allen DL, Harrison BC, Sartorius C, Byrnes WC, Leinwand LA (2001) Mutation of the IIB myosin heavy chain gene results in muscle fiber loss and compensatory hypertrophy. Am J Physiol Cell Physiol 280: C637-645.
24. Acharyya S, Butchbach ME, Sahenk Z, Wang H, Saji M, et al. (2005) Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 8: 421-432. (Pubitemid 41579836)
25. Li JB, Goldberg AL (1976) Effects of food deprivation on protein synthesis and degradation in rat skeletal muscles. Am J Physiol 231: 441-448.
26. Goldberg AL, Goodman HM (1969) Relationship between growth hormone and muscular work in determining muscle size. J Physiol 200: 655-666.
27. Tiao G, Lieberman M, Fischer JE, Hasselgren PO (1997) Intracellular regulation of protein degradation during sepsis is different in fast-and slowtwitch muscle. Am J Physiol 272: R849-856.
28. Baracos VE, DeVivo C, Hoyle DH, Goldberg AL (1995) Activation of the AT Pubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol 268: E996-1006.
29. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, et al. (2004) Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114: 370-378. (Pubitemid 39071609)
30. Drexler H, Riede U, Munzel T, Konig H, Funke E, et al. (1992) Alterations of skeletal muscle in chronic heart failure. Circulation 85: 1751-1759.
31. Diffee GM, Kalfas K, Al-Majid S, McCarthy DO (2002) Altered expression of skeletal muscle myosin isoforms in cancer cachexia. Am J Physiol Cell Physiol 283: C1376-1382. (Pubitemid 35178429)
32. Bhogal AS, Lorite ML, Tisdale MJ (2006) Changes in nucleic acid and protein levels in atrophying skeletal muscle in cancer cachexia. Anticancer Res 26: 4149-4154. (Pubitemid 46031484)
33. Stephens NA, Gray C, Macdonald AJ, Tan BH, Gallagher IJ, et al. (2012) Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function. Clin Nutr.
34. Lopes MN, Black P, Ashford AJ, Pain VM (1989) Protein metabolism in the tumour-bearing mouse. Rates of protein synthesis in host tissues and in an Ehrlich ascites tumour at different stages in tumour growth. Biochem J 264: 713-719. (Pubitemid 20023440)
35. Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, et al. (2005) Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122: 289-301. (Pubitemid 41032991)
36. Glass DJ (2010) Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 13: 225-229.
37. Smith KL, Tisdale MJ (1993) Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer 67: 680-685. (Pubitemid 23101543)
38. Samuels SE, Knowles AL, Tilignac T, Debiton E, Madelmont JC, et al. (2001) Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice. Am J Physiol Regul Integr Comp Physiol 281: R133-139.
39. Lecker SH, Solomon V, Mitch WE, Goldberg AL (1999) Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 129: 227S-237S. (Pubitemid 29035981)
40. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708. (Pubitemid 33104839)
41. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98: 14440-14445. (Pubitemid 33121410)
42. Stephens NA, Gallagher IJ, Rooyackers O, Skipworth RJ, Tan BH, et al. (2010) Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med 2: 1.
43. D'Orlando C, Marzetti E, Francois S, Lorenzi M, Conti V, et al. (2013) Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle. Muscle Nerve.
44. Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T (2001) Beclin- phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep 2: 330-335. (Pubitemid 32401529)
45. She P, Zhang Z, Marchionini D, Diaz WC, Jetton TJ, et al. (2011) Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's disease. Am J Physiol Endocrinol Metab 301: E49-61.
46. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, et al. (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298. (Pubitemid 39360909)
47. Kumar A, Bhatnagar S, Paul PK (2012) TWEAK and TRAF6 regulate skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care 15: 233-239.
48. Braun TP, Zhu X, Szumowski M, Scott GD, Grossberg AJ, et al. (2011) Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J Exp Med 208: 2449-2463.
49. Joulia-Ekaza D, Cabello G (2007) The myostatin gene: physiology and pharmacological relevance. Curr Opin Pharmacol 7: 310-315. (Pubitemid 46738500)
50. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA (1996) MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 10: 1173-1183. (Pubitemid 26171100)
51. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, et al. (2002) Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277: 49831-49840. (Pubitemid 36014431)
52. Ryan AS, Ivey FM, Prior S, Li G, Hafer-Macko C (2011) Skeletal muscle hypertrophy and muscle myostatin reduction after resistive training in stroke survivors. Stroke 42: 416-420.